<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">The Zoonoses Anticipation and Preparedness Initiative (ZAPI) is a public-private partnership project funded through the 
 <funding-source id="gs1">Innovative Medicines Initiative</funding-source> (
 <funding-source id="gs2">IMI</funding-source>). It aims to enable swift responses to major new infectious disease threats and deliver effective vaccines and therapeutic antibodies against (re-)emerging zoonotic diseases within a few months after first clinical cases, 
 <italic>i.e.,</italic> providing a One Health « standardized tool » to address disease outbreaks in animals and humans. The methodology comprise fast GMP production for several targets by identifying immunogenic subunit domains that are then coupled on protein scaffolds.
</p>
